Agenus granted ChemRar's NewVac LLC subsidiary exclusive rights to manufacture and commercialize Agenus's Oncophage vitespen

Agenus Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$43.0m on 12/30/2011 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

ChemRar High Tech Center

Russia / Tools, Services, and Manufacturing

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced